DMAAUDrugs Made In America Acquisition Corp. Units

NAS · US · Financial Services · Shell Companies

10.79USD0.00%Mkt Cap: —P/E: —4d ago

Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business …

Industry Peers

Shell Companies

Drugs Made In America Acquisition II Corp. Ordinary Shares

$645.92MUSDP/E 35.0

BCSS

Bain Capital GSS Investment Corp. Class A Ordinary Shares

$600.35MUSD

EVAC

EQV Ventures Acquisition Corp. II

$600.26MUSDP/E 14.7

CXII

Churchill Capital Corp XII Class A Ordinary Shares

$595.50MUSD

CEPF

Cantor Equity Partners IV Inc. Class A Ordinary Shares

$590.93MUSDP/E 27.9

AEXA

American Exceptionalism Acquisition Corp. A

$577.70MUSD

DBCA

D. Boral Acquisition I Corp. Class A Ordinary Shares

$555.37MUSD

VACH

Voyager Acquisition Corp Class A Ordinary Shares

$541.25MUSDP/E 81.5

GCGR

General Catalyst Global Resilience Merger Corp. Class A Ordinary Shares

$514.21MUSD

NWAX

New America Acquisition I Corp. Class A Common Stock

$506.96MUSD

MEVO

M Evo Global Acquisition Corp II Class A Ordinary Shares

$499.00MUSD

KRSP

Rice Acquisition Corporation 3

$487.63MUSD

RFAI

RF Acquisition Corp II Ordinary Shares

$483.94MUSDP/E 483.3

GIW

GigCapital8 Corp. Class A Ordinary Shares

$480.90MUSD

GTEN

Gores Holdings X Inc. Class A ordinary shares

$478.70MUSDP/E 6.9

ANSC

Agriculture & Natural Solutions Acquisition Corporation Class A Ordinary Shares

$476.13MUSDP/E 52.1

CRAN

Crane Harbor Acquisition Corp. II Class A Ordinary Shares

$475.57MUSD

APXT

APEX TECHNOLOGY ACQUISITION CORP

$464.43MUSD

IEAG

Infinite Eagle Acquisition Corp. Class A Ordinary Shares

$444.99MUSD

Key Statistics

Company

Market Cap—

Enterprise Value363.89M $

Revenue (TTM)—

Gross Profit—

Net Income (TTM)5.94M $

Revenue/Share—

Last Price10.79 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees—

CountryUS

SectorFinancial Services

IndustryShell Companies

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B-50.19

EPS (TTM)—

EPS (Forward)—

52W Range

10.3022% of range12.50

52W High12.50 USD

52W Low10.30 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE2.55%

ROA2.48%

Growth

Revenue Growth—

Earnings Growth18.80%

Cash Flow & Leverage

Operating CF-539.19K $

CapEx (TTM)—

FCF Margin—

FCF Yield—

Net Debt85.11K $

Net Debt/EBITDA—

Balance Sheet

Debt/Equity—

Current Ratio0.03

Quick Ratio0.03

Book Value/Sh-0.2150 USD

Cash/Share0.0000 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.29.17M

Float29.13M

Insiders17.88%

Institutions1.54%

Short Interest

Short Ratio40.2d

Shares Short883

Short (prev mo.)883

Technical

SMA 5010.85 (-0.5%)

SMA 20010.63 (+1.5%)

Beta—

S&P 52W Chg18.16%

Avg Vol (30d)64

Avg Vol (10d)10

Technical Indicators

RSI (14)37.7

MACD-0.0233

MACD Signal-0.0123

MACD Hist.-0.0111

BB Upper11.05 USD

BB Middle10.86 USD

BB Lower10.68 USD

BB Width3.34%

ATR (14)0.0197 USD

Vol Ratio (20d)0.00x